HUGE: FSD Pharma Company Aggregate Debts

Symbol and logo of brand fsdpharma.com (HUGE)

FSD Pharma Inc. (HUGE) focuses on developing therapies for complex brain pathologies, aiming for long-term profitability through patent protection. This price chart illustrates debt dynamics, which currently stand at 0.00, while Canadian developments remain shielded from trade wars. The business model relies on the high margins of global distribution for innovative drugs following their official approval.

FSD Pharma - HUGE Company Debts (period 07/04/2022 - 08/15/2024)

Analytical breakdowns and data insights for company FSD Pharma Inc. (HUGE)

- price and consensus price forecast:
Price Performance Chart FSD Pharma, Inc.|HUGE - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization FSD Pharma|HUGE - Total Company Value
- book capitalization data:
Accounting Value of a Share FSD Pharma|HUGE - Company Book Value|Market Cap to Net Assets Ratio fsdpharma.com|HUGE - Company Total Assets
- debt and liquidity data:
Total Debt to Capital FSD Pharma Inc.|HUGE - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital fsdpharma.com|HUGE - Company Debts|Debt to Book Value Ratio FSD Pharma|HUGE - Company Long-Term Debts|Short-Term Debt FSD Pharma
Analysis of all company metrics:HUGE FSD Pharma, Inc.
Original product of FSD Pharma, Inc.

This indicator reflects the aggregate volume of the business's external credit obligations, measuring the total amount of debt owed to financial institutions to assess the debt load. By analyzing the history of total debt, an investor can evaluate the balance between leveraged capital and the financial stability of FSD Pharma Inc. (HUGE), which is critical for sustaining costly innovative developments in the field of neurology.

Competitor analysis for FSD Pharma Inc.

Aggregate Debt Obligations Jazz Pharmaceuticals Corp (JAZZ)|Company Aggregate Debts CYTK (Cytokinetics)|ptcbio.com - Company Aggregate Debts|Company Debts Scholar Rock Holding Corporation (SRRK)|CNTA: Aggregate Debt Obligations|DYN (Dyne Pharma) - Company Debts|Edgewise Corp (EWTX) - Company Total Debt|RAPP (Rapport Therapeutics, Inc.) - Company Aggregate Debts|Company Aggregate Debts alumis.com (ALMS)|Zevra Therapeutics, Inc. (ZVRA) - Company Total Debt|Aggregate Debt Obligations CTNM (Contineum Therapeutics Inc)|LRMR - Company Debts|Company Aggregate Debt Capricor Therapeutics Inc. CAPR|TRDA (Entrada Therapeutics) - Company Aggregate Debts|channeltherapeutics.com (PTHS) - Company Cumulative Debt|MNOV: Company Total Debt|SER (Serina Therapeutics Inc) - Company Aggregate Debts|BTAI - Company Debts|Aggregate Debt Obligations PMN|Apimeds Pharmaceuticals - Company Debts|Company Cumulative Debt AEON (aeonbiopharma.com)|Company Debts NLS Pharmaceutics NLSP|Bionomics Ltd. - Company Debts|RETA (Reata) - Company Debts